Amneal Pharmaceuticals LLC. - Company & Market Research Reports

Amneal Pharmaceuticals is the fifth largest generic pharmaceutical manufacturer in the United States. Its products include buprenorphine and naloxone tablets, ear drops, scalp and body oils, liquid syrups, folic acid tablets, oral solids, nasal sprays, and more. The company was founded in 2002 and is based in Bridgewater, New Jersey with operations in the U.S., the UK, Spain, Scandinavia, Australia, and Germany. It has manufacturing plants in New York, New Jersey, and India; and sales operations and a distribution facility in Kentucky.

US Generic Drug Market Opportunity Outlook 2020 - Product Thumbnail Image

US Generic Drug Market Opportunity Outlook 2020

  • Report
  • 100 Pages
From
Global Generic Drug Litigation Updates 2018: Opportunities for Generic Companies Based on the Latest Para IV Events - Product Thumbnail Image

Global Generic Drug Litigation Updates 2018: Opportunities for Generic Companies Based on the Latest Para IV Events

  • Report
Important Para IV Events - Product Thumbnail Image

Important Para IV Events

  • Report
US Generic Drug Market Outlook 2018 - Product Thumbnail Image

US Generic Drug Market Outlook 2018

  • Report
  • 110 Pages
From
Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2016 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2016

  • Drug Pipelines
  • 73 Pages
From
Alzheimer's: Pipeline Assessment and Insights - Product Thumbnail Image

Alzheimer's: Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028 - Product Thumbnail Image

Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028

  • Report
  • 200 Pages
From
Pharmaceutical Contract Manufacturing Market (2nd Edition), 2018-2028 - Product Thumbnail Image

Pharmaceutical Contract Manufacturing Market (2nd Edition), 2018-2028

  • Report
  • 520 Pages
From
Biosimilars - Global Strategic Business Report - Product Thumbnail Image

Biosimilars - Global Strategic Business Report

  • Report
  • 243 Pages
From
Global Autoinjectors Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Global Autoinjectors Market (2nd Edition), 2018-2030

  • Report
  • 510 Pages
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • 611 Pages
From
Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a “Watchful Waiting” and Resistance Population - Product Thumbnail Image

Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a “Watchful Waiting” and Resistance Population

  • Report
  • 200 Pages
From
Global Allergy Rhinitis Drugs Market 2017-2021 - Product Thumbnail Image

Global Allergy Rhinitis Drugs Market 2017-2021

  • Report
  • 70 Pages
From
Anti-Hypertensive Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Hypertensive Drugs - Global Strategic Business Report

  • Report
  • 893 Pages
From
Hormone Replacement Therapy (HRT) - Global Strategic Business Report - Product Thumbnail Image

Hormone Replacement Therapy (HRT) - Global Strategic Business Report

  • Report
  • 198 Pages
From
Cystic Fibrosis: Epidemiology Overview and Insights - Product Thumbnail Image

Cystic Fibrosis: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
COPD: Market Intelligence Review and Insights - Product Thumbnail Image

COPD: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Active Pharmaceutical Ingredients Global Market - Forecast to 2022 - Product Thumbnail Image

Active Pharmaceutical Ingredients Global Market - Forecast to 2022

  • Report
  • 369 Pages
From
Global Chemotherapy-induced Nausea and Vomiting Market - Global Opportunities and Forecast 2014-2022 - Product Thumbnail Image

Global Chemotherapy-induced Nausea and Vomiting Market - Global Opportunities and Forecast 2014-2022

  • Report
  • 70 Pages
From
Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report - Product Thumbnail Image

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

  • Report
  • 565 Pages
From
Loading Indicator
adroll